Filing Details

Accession Number:
0000899243-20-026891
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-02 17:07:24
Reporting Period:
2020-10-01
Accepted Time:
2020-10-02 17:07:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1701541 Black Diamond Therapeutics Inc. BDTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1488668 M. David Epstein C/O Black Diamond Therapeutics, Inc.
139 Main Street
Cambridge MA 02142
See Remarks Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-10-01 3,000 $6.42 732,923 No 4 M Direct
Common Stock Disposition 2020-10-01 12,000 $30.33 720,923 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-10-01 3,000 $0.00 3,000 $6.42
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
241,616 2029-08-13 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 23,090 Indirect See footnote
Common Stock 104,449 Indirect See footnote
Common Stock 104,449 Indirect See footnote
Common Stock 16,579 Indirect See footnote
Common Stock 16,579 Indirect See footnote
Footnotes
  1. Shares sold pursuant to a pre-established 10b5-1 trading plan effective as of June 12, 2020.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.10 to $30.64 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  3. Shares held by wife.
  4. Shares held by David M. Epstein 2019 Trust For Elle. David M. Epstein is the trustee of the David M. Epstein 2019 Trust for Elle and may be deemed to beneficially own these securities.
  5. Shares held by David M. Epstein 2019 Trust For Zoe. David M. Epstein is the trustee of the David M. Epstein 2019 Trust for Zoe and may be deemed to beneficially own these securities.
  6. Shares held by David M. Epstein 2019 Trust For Robert. David M. Epstein is the trustee of the David M. Epstein 2019 Trust for Robert and may be deemed to beneficially own these securities.
  7. Shares held by David M. Epstein 2019 Trust For Shelley. David M. Epstein is the trustee of the David M. Epstein 2019 Trust for Shelley and may be deemed to beneficially own these securities.
  8. 25% of the shares subject to this option vested and became exercisable on August 14, 2020, with the remainder vesting in 36 equal monthly installments thereafter.